Anpario plc (LON:ANP - Get Free Report) crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of GBX 396.57 ($5.28) and traded as high as GBX 453 ($6.03). Anpario shares last traded at GBX 443.55 ($5.90), with a volume of 126,377 shares changing hands.
Analyst Upgrades and Downgrades
Separately, Shore Capital reiterated a "house stock" rating on shares of Anpario in a research note on Monday, March 31st.
Get Our Latest Stock Report on ANP
Anpario Stock Up 1.6%
The business's 50 day moving average price is GBX 400.20 and its 200-day moving average price is GBX 396.57. The company has a debt-to-equity ratio of 0.10, a current ratio of 6.15 and a quick ratio of 5.16. The company has a market cap of £77.57 million, a P/E ratio of 25.11 and a beta of 0.58.
Anpario (LON:ANP - Get Free Report) last posted its earnings results on Monday, March 31st. The company reported GBX 28.40 ($0.38) earnings per share (EPS) for the quarter. Anpario had a net margin of 9.23% and a return on equity of 8.74%. On average, analysts anticipate that Anpario plc will post 23.5757801 earnings per share for the current fiscal year.
Anpario Increases Dividend
The business also recently disclosed a dividend, which will be paid on Friday, July 25th. Investors of record on Thursday, July 10th will be given a GBX 8 ($0.11) dividend. This represents a yield of 2.09%. The ex-dividend date is Thursday, July 10th. This is a boost from Anpario's previous dividend of $3.25. Anpario's payout ratio is 60.74%.
Insider Buying and Selling
In other Anpario news, insider Marc Wilson bought 3,778 shares of the stock in a transaction on Tuesday, April 1st. The stock was purchased at an average price of GBX 398 ($5.30) per share, with a total value of £15,036.44 ($20,011.23). 30.51% of the stock is currently owned by corporate insiders.
Anpario Company Profile
(
Get Free Report)
Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Anpario, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.
While Anpario currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
